Tue, November 15, 2022

Andrew Fein Maintained (SYRS) at Strong Buy with Increased Target to $20 on, Nov 15th, 2022

Andrew Fein of HC Wainwright & Co., Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy with Increased Target from $6 to $20 on, Nov 15th, 2022.

Andrew, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30